Top Markets
#1 Black Phoenix Black Phoenix +734.10%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 TENDIES TENDIES +24.76%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.17%
#5 MetaDAO MetaDAO +16.98%
#6 THORChain THORChain +13.86%
#7 Biconomy Biconomy +13.36%
#8 Akedo Akedo +10.89%
#9 THORChain Yield THORChain Yield +10.14%
#10 Bless Bless +9.78%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Kedudukan dalam Saham #4906
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Harga Saham
$3.47
Modal Pasaran
$3.19B
Perubahan (1 hari)
0.34%
Perubahan (1 tahun)
-51.18%
Negara
CN
Perdagangan Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategori

Healthcare
Pendapatan untuk Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Hebei Changshan Biochemical Pharmaceutical Co., Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Hebei Changshan Biochemical Pharmaceutical Co., Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH